Page last updated: 2024-08-26

lopinavir and Shock, Cardiogenic

lopinavir has been researched along with Shock, Cardiogenic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Alharthy, A; Alshaya, R; Brindley, PG; Faqihi, F; Karakitsos, D; Kutsogiannis, DJ; Papanikolaou, J	1

Other Studies

1 other study(ies) available for lopinavir and Shock, Cardiogenic

Article	Year
Reverse takotsubo cardiomyopathy in fulminant COVID-19 associated with cytokine release syndrome and resolution following therapeutic plasma exchange: a case-report. BMC cardiovascular disorders, 2020, 08-26, Volume: 20, Issue:1 Topics: Adult; Antiviral Agents; Betacoronavirus; Cardiotonic Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Combinations; Echocardiography; Humans; Lopinavir; Male; Pandemics; Plasma Exchange; Pneumonia, Viral; Respiration, Artificial; Respiratory Distress Syndrome; Ritonavir; SARS-CoV-2; Shock, Cardiogenic; Takotsubo Cardiomyopathy	2020

Article

Year

Reverse takotsubo cardiomyopathy in fulminant COVID-19 associated with cytokine release syndrome and resolution following therapeutic plasma exchange: a case-report.

BMC cardiovascular disorders, 2020, 08-26, Volume: 20, Issue:1

Topics: Adult; Antiviral Agents; Betacoronavirus; Cardiotonic Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Combinations; Echocardiography; Humans; Lopinavir; Male; Pandemics; Plasma Exchange; Pneumonia, Viral; Respiration, Artificial; Respiratory Distress Syndrome; Ritonavir; SARS-CoV-2; Shock, Cardiogenic; Takotsubo Cardiomyopathy

2020